Stifel Financial’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Sell |
311,107
-17,859
| -5% | -$147K | ﹤0.01% | 1666 |
|
|
2025
Q1 | $2.35M | Buy |
328,966
+140,122
| +74% | +$1M | ﹤0.01% | 1647 |
|
|
2024
Q4 | $1.46M | Buy |
188,844
+39,564
| +27% | +$306K | ﹤0.01% | 2001 |
|
|
2024
Q3 | $1.57M | Buy |
149,280
+17,563
| +13% | +$184K | ﹤0.01% | 1934 |
|
|
2024
Q2 | $1.54M | Buy |
131,717
+41,122
| +45% | +$481K | ﹤0.01% | 1903 |
|
|
2024
Q1 | $1.91M | Buy |
90,595
+22,646
| +33% | +$477K | ﹤0.01% | 1754 |
|
|
2023
Q4 | $1.22M | Buy |
67,949
+2,148
| +3% | +$38.6K | ﹤0.01% | 2009 |
|
|
2023
Q3 | $1.08M | Buy |
65,801
+5,824
| +10% | +$95.9K | ﹤0.01% | 2000 |
|
|
2023
Q2 | $1.2M | Buy |
59,977
+13,678
| +30% | +$273K | ﹤0.01% | 1963 |
|
|
2023
Q1 | $876K | Buy |
46,299
+12,004
| +35% | +$227K | ﹤0.01% | 2145 |
|
|
2022
Q4 | $778K | Buy |
34,295
+6,497
| +23% | +$147K | ﹤0.01% | 2182 |
|
|
2022
Q3 | $735K | Buy |
27,798
+2,538
| +10% | +$67.1K | ﹤0.01% | 2177 |
|
|
2022
Q2 | $624K | Buy |
25,260
+4,751
| +23% | +$117K | ﹤0.01% | 2336 |
|
|
2022
Q1 | $681K | Buy |
20,509
+5,626
| +38% | +$187K | ﹤0.01% | 2388 |
|
|
2021
Q4 | $487K | Buy |
14,883
+3,975
| +36% | +$130K | ﹤0.01% | 2602 |
|
|
2021
Q3 | $457K | Buy |
10,908
+4,669
| +75% | +$196K | ﹤0.01% | 2624 |
|
|
2021
Q2 | $242K | Buy |
+6,239
| New | +$242K | ﹤0.01% | 3037 |
|